Product Program year 2025 Source: CMS Open Payments

Absorica LD

Drug Dermatology

NDC 10631-002-31

Open in the dashboard

General payments

$1,748,306

47,493 payments

Research payments

$74,963

3 payments

Through program year 2025, $1,748,306 in general payments and $74,963 in research payments were reported against Absorica LD (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $1,094 11
2024 General $190,532 7,134
2023 General $665,370 14,783
2023 Research $59,970 2
2022 General $339,300 9,835
2021 General $315,455 11,790
2021 Research $14,993 1
2020 General $236,557 3,940

Breakdown

Who paid General payments · program years 2020–2025
  1. Sun Pharmaceutical Industries Inc. $1,748,306 47,493 payments
Top recipients General payments · program year 2025
  1. Ronald Berna Internal Medicine · Moorestown, NJ $102 9% · 1 payment
  2. Alexis Holmes Dermatology · Philadelphia, PA $102 9% · 1 payment
  3. Sung Cho Nurse Practitioner, Primary Care · Mesa, AZ $102 9% · 1 payment
  4. Ngan DO Dermatology · Philadelphia, PA $102 9% · 1 payment
  5. Caroline Myers Dermatology · Philadelphia, PA $102 9% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $787 79% · 8 practitioners
  2. Internal Medicine $102 10% · 1 practitioner
  3. Nurse Practitioner, Primary Care Nurse Practitioner $102 10% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Pennsylvania $614 56% · 6 recipients
  2. Arizona $102 9% · 1 recipient
  3. Maryland $102 9% · 1 recipient
  4. Massachusetts $102 9% · 1 recipient
  5. New Jersey $102 9% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

47,493 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record